Extavia
Generic name: Interferon Beta-1b
Drug class:
Interferons
Usage of Extavia
Extavia is made from human proteins. Extavia is similar to certain interferon proteins that are produced in the body. Interferons help the body fight viral infections.
Extavia is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS). This medicine will not cure MS, but it may decrease flare-ups.
It is not known if Extavia is safe and effective in children. .
Extavia side effects
Get emergency medical help if you have signs of an allergic reaction to Extavia: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some patients using interferon medicines have become very depressed or had thoughts of suicide. Report any new or worsening symptoms of depression to your doctor, such as: mood or behavior changes, anxiety, trouble sleeping, hallucinations, or if you feel impulsive, hostile, aggressive, depressed, or have thoughts about suicide or hurting yourself.
Stop using Extavia and call your doctor at once if you have:
Common Extavia side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Extavia
You should not use Extavia if you are allergic to interferon beta, albumin, or mannitol.
To make sure Extavia is safe for you, tell your doctor if you have:
Tell your doctor if you are pregnant or breastfeeding.
Relate drugs
- Actimmune
- Alferon N
- Avonex
- Avonex Pen
- Avonex Prefilled Syringe
- Betaseron
- Extavia
- Interferon alfa-n3
- Interferon beta-1a
- Interferon beta-1b
- Interferon gamma-1b
- Peginterferon beta-1a
- Plegridy
- Plegridy Pen
- Plegridy Pen Starter Pack
- Rebif
- Rebif Rebidose
- Rebif Rebidose Titration Pack
How to use Extavia
Usual Adult Dose for Multiple Sclerosis:
Initial dose: 0.0625 mg subcutaneously every other day, and increased (in 25% increments) every 2 weeks, over a 6 week period, to maintenance dose Maintenance dose: 0.25 mg subcutaneously every other day Schedule for dose titration: Weeks 1 and 2: 0.0625 mg subcutaneously every other day (25% of recommended dose) Weeks 3 and 4: 0.125 mg subcutaneously every other day (50% of recommended dose) Weeks 5 and 6: 0.1875 mg subcutaneously every other day (75% of recommended dose) Week 7 and beyond: 0.25 mg subcutaneously every other day (100% of recommended dose) Use: For the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Warnings
Extavia may be harmful to an unborn baby, or may cause a miscarriage. Do not use Extavia if you are pregnant. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
Before using Extavia, tell your doctor if you are allergic to any drugs, or if you have liver disease, a thyroid disorder, epilepsy or other seizure disorder, a bleeding or blood-clotting disorder, anemia (low red blood cells), or a history of depression or suicidal behavior.
Some people have thoughts about suicide while taking interferon beta-1b. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.
Interferon beta-1b can harm your liver. Call your doctor at once if you have nausea, vomiting, itching, bruising or bleeding, or yellowing of your skin or eyes.
To be sure Extavia is not causing harmful effects, your blood and liver function will need to be tested on a regular basis. Your thyroid function may also need to be tested. Do not miss any scheduled appointments.
What other drugs will affect Extavia
Other drugs may interact with interferon beta-1b, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions